| Autor: |
Weerasooriya W A L K, Abeyagunawardana A S, Thalgahagoda RS |
| Rok vydání: |
2022 |
| DOI: |
10.21203/rs.3.rs-1690099/v1 |
| Popis: |
Background: Nephrotic syndrome is the commonest glomerular disease in childhood. It usually follows a relapsing and remitting course. Corticosteroids are the mainstay of treatment for both the first episode and subsequent relapses.Objective: This study was conducted at a single centre to compare the clinical response to a single dose vs. split dose of prednisolone in the treatment of relapses of childhood nephrotic syndrome.Method: Children between the ages of 1 and 14 years admitted with a relapse of nephrotic syndrome from August 2019 to February 2020 were evaluated. A block randomization method based on age was used for sampling. Patients randomised to Group A received oral prednisolone at 60mg/m2 as a single morning dose, while those randomised to Group B received the same total dose as two divided doses, of which 2/3 was given in the morning and the rest in the evening. Treatment was continued until remission was achieved following which all patients were switched to alternate day prednisolone. An independent sample t-test was used to compare the two groups.Results: 104 episodes of relapse occurring in 96 children were included of which 49 were treated with prednisolone as a split dose and 55 were treated with a single dose of prednisolone. The mean duration to achieve remission for the split dose group was 8.02 days (SD 1.58) while it was 9.74 days (SD 3.72) for the single dose group. This difference was statistically highly significant (t (102) = 3.004; p=0.001; CI 0.58 to 2.86). There was no difference in the side effect profile of the two groups.Conclusion: The use of prednisolone as a split dose results in a shorter duration to achieve remission when compared to a single morning dose, resulting in a lower cumulative dose of prednisolone to achieve remission. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
